aod9604 slu pp 332 bloend Drops | AOD | 30mg SLU-PP-332 - Polar Peptides

SeekPeptides has analyzed the available safety literature and community reports to give you the most comprehensive resource on this topic

While clinical studies have demonstrated its fat-reducing potential, AOD-9604 has not been fully validated as an FDA-approved weight loss therapy

Research Findings on AOD-9604 Key findings from preclinical research include: Lipolytic activity: Stimulates fat breakdown in adipocyte cultures and animal models

Glucose Metabolism: Growth hormone is known to impair glucose tolerance and insulin sensitivity, sometimes precipitating diabetes or worsening glycemic control in diabetic patients